State-dependent inhibition of cystic fibrosis transmembrane conductance regulator chloride channels by a novel peptide toxin

被引:37
作者
Fuller, Matthew D. [1 ,2 ]
Thompson, Christopher H. [2 ]
Zhang, Zhi-Ren [2 ]
Freeman, Cody S. [2 ]
Schay, Eszter [3 ]
Szakacs, Gergely [3 ,4 ]
Bakos, Eva [3 ]
Sarkadi, Balazs [4 ]
McMaster, Denis
French, Robert J. [1 ,5 ,6 ]
Pohl, Jan [7 ]
Kubanek, Julia [2 ,8 ]
McCarty, Nael A. [2 ]
机构
[1] Emory Univ, Program Mol & Syst Pharmacol, Atlanta, GA 30322 USA
[2] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA
[3] Hungarian Acad Sci, Inst Enzymol, H-1113 Budapest, Hungary
[4] Hungarian Acad Sci, Natl Med Ctr, Inst Haematol & Immunol, H-1113 Budapest, Hungary
[5] Univ Calgary, Peptide Synth Core Facil, Calgary, AB T2N 4N1, Canada
[6] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada
[7] Emory Univ, Microchem & Proteom Facil, Atlanta, GA 30322 USA
[8] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA
关键词
D O I
10.1074/jbc.M708079200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peptide toxins from animal venom have been used for many years for the identification and study of cation-permeable ion channels. However, no peptide toxins have been identified that interact with known anion-selective channels, including cystic fibrosis transmembrane conductance regulator (CFTR), the protein defective in cystic fibrosis and a member of the ABC transporter superfamily. Here, we describe the identification and initial characterization of a novel 3.7-kDa peptide toxin, GaTx1, which is a potent and reversible inhibitor of CFTR, acting from the cytoplasmic side of the membrane. Thus, GaTx1 is the first peptide toxin identified that inhibits a chloride channel of known molecular identity. GaTx1 exhibited high specificity, showing no effect on a panel of nine transport proteins, including Cl- and K+ channels, and ABC transporters. GaTx1-mediated inhibition of CFTR channel activity is strongly state-dependent; both potency and efficacy are reduced under conditions of elevated [ATP], suggesting that GaTx1 may function as a non-competitive inhibitor of ATP-dependent channel gating. This tool will allow the application of new quantitative approaches to study CFTR structure and function, particularly with respect to the conformational changes that underlie transitions between open and closed states.
引用
收藏
页码:37545 / 37555
页数:11
相关论文
共 68 条
[1]   Alternative treatment for secretory diarrhea revealed in a new class of CFTR inhibitors [J].
Ai-Awqati, Q .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (11) :1599-1601
[2]   Activation of wild type and ΔF508-CFTR by phosphodiesterase inhibitors through cAMP-dependent and -independent mechanisms [J].
Al-Nakkash, L ;
Hwang, TC .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1999, 437 (04) :553-561
[3]   NUCLEOSIDE TRIPHOSPHATES ARE REQUIRED TO OPEN THE CFTR CHLORIDE CHANNEL [J].
ANDERSON, MP ;
BERGER, HA ;
RICH, DP ;
GREGORY, RJ ;
SMITH, AE ;
WELSH, MJ .
CELL, 1991, 67 (04) :775-784
[4]   Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain [J].
Bakos, E ;
Evers, R ;
Szakács, G ;
Tusnády, GE ;
Welker, E ;
Szabó, K ;
de Haas, M ;
van Deemter, L ;
Borst, P ;
Váradi, A ;
Sarkadi, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :32167-32175
[5]   Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions [J].
Bakos, É ;
Evers, R ;
Sinkó, E ;
Váradi, A ;
Borst, P ;
Sarkadi, B .
MOLECULAR PHARMACOLOGY, 2000, 57 (04) :760-768
[6]   COUPLING OF CFTR CL- CHANNEL GATING TO AN ATP HYDROLYSIS CYCLE [J].
BAUKROWITZ, T ;
HWANG, TC ;
GADSBY, DC ;
NAIRN, AC .
NEURON, 1994, 12 (03) :473-482
[7]   ACTION OF DERIVATIVES OF MU-CONOTOXIN-GIIIA ON SODIUM-CHANNELS - SINGLE AMINO-ACID SUBSTITUTIONS IN THE TOXIN SEPARATELY AFFECT ASSOCIATION AND DISSOCIATION RATES [J].
BECKER, S ;
PRUSAKSOCHACZEWSKI, E ;
ZAMPONI, G ;
BECKSICKINGER, AG ;
GORDON, RD ;
FRENCH, RJ .
BIOCHEMISTRY, 1992, 31 (35) :8229-8238
[8]   PHOSPHATASE INHIBITORS ACTIVATE NORMAL AND DEFECTIVE CFTR CHLORIDE CHANNELS [J].
BECQ, F ;
JENSEN, TJ ;
CHANG, XB ;
SAVOIA, A ;
ROMMENS, JM ;
TSUI, LC ;
BUCHWALD, M ;
RIORDAN, JR ;
HANRAHAN, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :9160-9164
[9]  
Berger W, 1997, INT J CANCER, V71, P108, DOI 10.1002/(SICI)1097-0215(19970328)71:1<108::AID-IJC18>3.0.CO
[10]  
2-E